CLGN
CollPlant Biotechnologies Ltd - Ordinary Shares New

600
Mkt Cap
$23.02M
Volume
29,963.00
52W High
$4.98
52W Low
$1.31
PE Ratio
-1.77
CLGN Fundamentals
Price
$1.90
Prev Close
$1.81
Open
$1.78
50D MA
$2.19
Beta
0.24
Avg. Volume
19,932.26
EPS (Annual)
-$1.45
P/B
2.49
Rev/Employee
$9,035.09
Loading...
Loading...
News
all
press releases
CLGN Stock Crashed 14% Today – Disappointing Earnings, Workforce Reduction Plan Draws Investor Attention
The firm reported revenue of $77,000 for the three months ended September, above the $4,000 reported in the corresponding quarter of 2024, but below an analyst estimate of $5.03 million, according to data from Fiscal AI.
Stocktwits·15d ago
News Placeholder
More News
News Placeholder
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE...
PR Newswire·15d ago
News Placeholder
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS PR Newswire REHOVOT, Israel, Nov...
PR Newswire·23d ago
News Placeholder
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada
CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada CollPlant Expands its rhCollagen Distribution Capabilities in the United States and Canada PR Newswire...
PR Newswire·2mo ago
News Placeholder
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk
First-in-Kind Fully Humanized 3D Bioprinted Human Skin Model Developed by Mayo Clinic Researchers using CollPlant's rhCollagen-Based BioInk First-in-Kind Fully Humanized 3D Bioprinted Human Skin...
PR Newswire·2mo ago
News Placeholder
CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia
CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia PR Newswire REHOVOT, Israel, Feb. 24, 2025...
PR Newswire·10mo ago

Latest CLGN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.